Search Results 151-160 of 3081 for Mão Morta de Volkmann

  1. Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. A Study Evaluating the Addition of Venetoclax (ABT-199) to Patients with Multiple Myeloma who are Receiving Bortezomib and Dexamethasone as Standard Therapy - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of venetoclax, added to treatment with bortezomib and dexamethasone in patients who have ...

  3. https://www.mayoclinic.org/condition_consolidated_concepts.xml

  4. Publications

    Thongprayoon C, Vaitla P, Jadlowiec CC, Leeaphorn N, Mao SA, Mao MA, Pattharanitima P, Bruminhent J, Khoury NJ, Garovic VD, Cooper M, Cheungpasitporn W. Use ...

  5. Waist Circumference Measurement and Weight Changes Over Time for Assessment of Metabolic Syndrome in Overweight and Obese Children in an Outpatient Clinic Setting

    Educate providers and nursing staff on the importance and technique of measuring the WC in the overweight and obese outpatient pediatric population with at ...

  6. A Phase 1 Proof-of-Concept Clinical Trial Evaluating the Safety and Tolerability of Midodrine in Hepatopulmonary Syndrome

    The purpose of this study is to assess the safety and tolerability of midodrine in patients with Hepatopulmonary Syndrome (HPS). Participation eligibility.

  7. Faculty - Neurosurgery Research - Mayo Clinic Research

    Experts in biomedical engineering, neurosurgery, neurology, orthopedics and more guide research in Mayo Clinic's Department of Neurologic Surgery.

  8. Vascular Diseases Biorepository - Mayo Clinic

    About this study. The eventual goal of this study is to identify genetic and proteomic markers that may influence susceptibility to vascular diseases ...

  9. A Study of JNJ‐68284528 Out‐of‐Specification (OOS) for Commercial Release in Patients with Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to evaluate the effectiveness of cilta-cel OOS based on overall response of partial response (PR) or better ...

  10. Lionel A. Kankeu Fonkoua, M.D. - Mayo Clinic Faculty Profiles

    Lionel Aurelien (Lionel) A. Kankeu Fonkoua, M.D., is a medical oncologist at Mayo Clinic who studies ways to boost immunotherapy for gastrointestinal and ...